Magnetar Financial »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Magnetar Financial

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Magnetar Financial from 13F filings

Historical chart of Magnetar Financial investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Magnetar Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Magnetar Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $41M 36M 1.14

More positions owned by Magnetar Financial

Elanco Animal Health (ELAN)
Globus Med Cl A (GMED)
Sanofi Sponsored Adr (SNY)
Juniper Networks (JNPR)
Stericycle (SRCL)
Southwestern Energy Company
Cigna Corp (CI)
Axonics Modulation Technolog (AXNX)
McKesson Corporation (MCK)
Kellogg Company (K)
Discover Financial Services (DFS)
Thermo Fisher Scientific (TMO)
Johnson & Johnson (JNJ)
Hashicorp Com Cl A (HCP)
Albertsons Cos Common Stock (ACI)

View all positions for Magnetar Financial

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1